SHSE:605369 (China)
Â
Class A
Â¥
33.94
(+9.8%)
Sep 30
Business Description
Zhejiang Gongdong Medical Technology Co Ltd
ISIN : CNE1000042X4
Share Class Description:
SHSE:605369: Class ACompare
Compare
Traded in other countries / regions
605369.China IPO Date
2020-09-16Description
Zhejiang Gongdong Medical Technology Co Ltd is engaged in production and sales of disposable medical devices, and medical testing supplies. The company's products include Vacuum Blood collection system; Specimen Collection system; Petri Dish Family; Centrifugation Tube; Vaginal Speculum; Surgical Supplies; Pipette tip; Transfer Pipette; Test Tube; Test Tube Racks; and Colorimetric Cup.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 14.88 | |||||
| Equity-to-Asset | 0.88 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.21 | |||||
| Interest Coverage | 6.45 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 15.15 | |||||
| Beneish M-Score | -2.38 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.8 | |||||
| 3-Year EBITDA Growth Rate | -16.3 | |||||
| 3-Year EPS without NRI Growth Rate | -25.9 | |||||
| 3-Year FCF Growth Rate | -27.3 | |||||
| 3-Year Book Growth Rate | 10.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 45.16 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 22.91 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 87.86 | |||||
| 9-Day RSI | 79.76 | |||||
| 14-Day RSI | 74.04 | |||||
| 6-1 Month Momentum % | -11.84 | |||||
| 12-1 Month Momentum % | -29.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.56 | |||||
| Quick Ratio | 4 | |||||
| Cash Ratio | 2.52 | |||||
| Days Inventory | 59.53 | |||||
| Days Sales Outstanding | 79.95 | |||||
| Days Payable | 42.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.94 | |||||
| Dividend Payout Ratio | 0.38 | |||||
| Forward Dividend Yield % | 1.94 | |||||
| 5-Year Yield-on-Cost % | 1.94 | |||||
| 3-Year Average Share Buyback Ratio | -0.2 | |||||
| Shareholder Yield % | 1.46 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.15 | |||||
| Operating Margin % | 14.15 | |||||
| Net Margin % | 13.4 | |||||
| FCF Margin % | 8.25 | |||||
| ROE % | 8.66 | |||||
| ROA % | 7.57 | |||||
| ROIC % | 11.06 | |||||
| 3-Year ROIIC % | -15.76 | |||||
| ROC (Joel Greenblatt) % | 19.56 | |||||
| ROCE % | 9.47 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 37.21 | |||||
| Forward PE Ratio | 17.67 | |||||
| PE Ratio without NRI | 36.18 | |||||
| Price-to-Owner-Earnings | 998.24 | |||||
| PEG Ratio | 3.12 | |||||
| PS Ratio | 4.51 | |||||
| PB Ratio | 3.14 | |||||
| Price-to-Tangible-Book | 3.9 | |||||
| Price-to-Free-Cash-Flow | 54.13 | |||||
| Price-to-Operating-Cash-Flow | 26.49 | |||||
| EV-to-EBIT | 30.48 | |||||
| EV-to-EBITDA | 30.48 | |||||
| EV-to-Revenue | 4.56 | |||||
| EV-to-FCF | 55.24 | |||||
| Price-to-Peter-Lynch-Fair-Value | 4.26 | |||||
| Price-to-Graham-Number | 2.5 | |||||
| Price-to-Net-Current-Asset-Value | 8.02 | |||||
| Price-to-Net-Cash | 20.57 | |||||
| Earnings Yield (Greenblatt) % | 3.28 | |||||
| FCF Yield % | 1.65 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhejiang Gongdong Medical Technology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,070.601 | ||
| EPS (TTM) (Â¥) | 0.912 | ||
| Beta | 1.52 | ||
| Volatility % | 44.2 | ||
| 14-Day RSI | 74.04 | ||
| 14-Day ATR (Â¥) | 1.170024 | ||
| 20-Day SMA (Â¥) | 29.3965 | ||
| 12-1 Month Momentum % | -29.06 | ||
| 52-Week Range (Â¥) | 24.342857 - 43.435714 | ||
| Shares Outstanding (Mil) | 157.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zhejiang Gongdong Medical Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zhejiang Gongdong Medical Technology Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zhejiang Gongdong Medical Technology Co Ltd Frequently Asked Questions
What is Zhejiang Gongdong Medical Technology Co Ltd(SHSE:605369)'s stock price today?
The current price of SHSE:605369 is ¥33.94. The 52 week high of SHSE:605369 is ¥43.44 and 52 week low is ¥24.34.
When is next earnings date of Zhejiang Gongdong Medical Technology Co Ltd(SHSE:605369)?
The next earnings date of Zhejiang Gongdong Medical Technology Co Ltd(SHSE:605369) is .
Does Zhejiang Gongdong Medical Technology Co Ltd(SHSE:605369) pay dividends? If so, how much?
The Dividend Yield %  of Zhejiang Gongdong Medical Technology Co Ltd(SHSE:605369) is 1.94% (As of Today), Highest Dividend Payout Ratio of Zhejiang Gongdong Medical Technology Co Ltd(SHSE:605369) was 0.83. The lowest was 0.38. And the median was 0.49. The  Forward Dividend Yield % of Zhejiang Gongdong Medical Technology Co Ltd(SHSE:605369) is 1.94%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers